Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Spending on medicines grew less than one percent in 2017

By Holly Campbell  |    April 19, 2018
Last year, a record number of new treatments and cures that are transforming care for patients fighting debilitating diseases like cancer, hepatitis C, high cholesterol and more were approved by the...   Read More

Celebrating hope for patients and families on World Heart Day 2016

By Hannah Mooney Mack  |    September 29, 2016
My heart lives in Portland, Ore. The reason I do my work is there too. That’s where I grew up and where I saw my grandfather earlier this month. If you ask him how he is doing, he’ll say, “I’m doing...   Read More

Burden on patients: Insurance benefit design’s impact on patient access to medicines

By Allyson Funk  |    June 30, 2016
Last week, we looked at access to medicines in health insurance exchanges for HIV/AIDS, oncology, cystic fibrosis, mental health and multiple sclerosis. The analysis by Avalere Health presents data...   Read More

New report celebrates a decade of progress in chronic diseases

By Holly Campbell  |    February 25, 2016
In the last 10 years, incredible progress has been made by the biopharmaceutical industry in the treatment of chronic diseases. With about half of all Americans, or 117 million people, living with...   Read More

Celebrating brighter futures and healthier hearts during American Heart Month

By Hannah Mooney Mack  |    February 10, 2016
This weekend on Valentine’s Day, we take time to celebrate our friends, family and significant others with acts of love and attention. But we also have the opportunity during American Heart Month to...   Read More

Critics proven wrong again on medicine spending

By Holly Campbell  |    December 9, 2015
Recent comments from pharmacy benefit managers and insurers disprove – once again – the fallacious claims previously made about spending on new innovative medicines. Over the past year, payers...   Read More

ICYMI: New cholesterol-lowering medicines will not be “budget busters”

By Holly Campbell  |    October 8, 2015
In case you missed it, Express Scripts, the nation’s largest pharmacy benefit manager, announced that it will include two new cholesterol-lowering medicines, called PCSK9 inhibitors, on its national...   Read More

Celebrating cardiovascular health on World Heart Day 2015

By Hannah Mooney Mack  |    September 29, 2015
Today, we celebrate more heartbeats with World Heart Day. With a focus on cardiovascular disease and the promoting of healthier heart hygiene, World Heart Day is an opportunity to acknowledge...   Read More

Value at the crossroads, part II

By Randy Burkholder  |    September 8, 2015
Value assessment in health care continues to generate considerable interest, as reflected in the wide range of comments sent to the American Society of Clinical Oncology (ASCO) on their Value...   Read More

No Two Patients with High Cholesterol are the Same: Meet George and Betty

By Holly Campbell  |    July 28, 2015
Last week, we introduced two hypothetical patients, Sheryl and Bill, who are working to get their cholesterol levels under control. Today we highlight George and Betty. George is able to control his...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates